People · Operator
Named in public records as an officer, director or promoter · active 2009–2014 · Other Technology, Pharmaceuticals, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Valeritas Inc | — | Other Technology | Series C | $106.5M | $689.9M | 2011 |
| Paratek Pharmaceuticals Inc | — | Pharmaceuticals | Series C | $93.0M | $3.3B | 2014 |
| PrimeraDx, Inc. | — | Biotechnology | Series B | $20.9M | $784.3M | 2009 |
Michael Bigham at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Michael Bigham on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Ryan | 1 | 17 |
| Richard Lim | 1 | 14 |
| Todd Foley | 1 | 12 |
| Nina Kjellson | 1 | 11 |
| Ittai Harel | 1 | 6 |
| Daniel Pelak | 1 | 5 |
| Ronald Lennox | 1 | 3 |
| Kristine Peterson | 1 | 3 |
| Sean Traynor | 1 | 3 |
| John Barr | 1 | 3 |
| Vaughn Kailian | 1 | 3 |
| Martin Verhoef | 1 | 3 |
| Evan Loh | 1 | 2 |
| James Dentzer | 1 | 2 |
| Paul Queally | 1 | 2 |
| William Duke | 1 | 2 |
| Dennis Molnar | 1 | 2 |
| Vincent Miles | 1 | 2 |
| Norhalim Yunus | 1 | 2 |
| Kathryn Boxmeyer | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.